291
Views
40
CrossRef citations to date
0
Altmetric
Original Article

Treadmill Gait Analysis Does Not Detect Motor Deficits in Animal Models of Parkinson's Disease or Amyotrophic Lateral Sclerosis

, , , &
Pages 568-577 | Published online: 07 Aug 2010

References

  • Amende, I., Kale, A., McCue, S., Glazier, S., Morgan, J. P., & Hampton, T. G. (2005). Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. Journal of Neuroengineering Rehabilitation, 2, 20.
  • Barneoud, P., Lolivier, J., Sanger, D. J., Scatton, B. & Moser, P. (1997). Quantitative motor assessment in FALS mice: A longitudinal study. Neuroreport, 8, 2861-2865.
  • Caudle, W. M., Tillerson, J. L., Reveron, M. E., & Miller, G. W. (2007). Use-dependent behavioral and neurochemical asymmetry in MPTP mice. Neuroscience Letters, 418, 213-216.
  • Chien, S. L., Lin, S. Z., Liang, C. C., Soong, Y. S., Lin, S. H., Hsin, Y. L., et al. (2006). The efficacy of quantitative gait analysis by the GAITRite system in evaluation of parkinsonian bradykinesia. Parkinsonism Related Disorders, 12, 438-442.
  • Clarke, K. A., & Still, J. (1999). Gait analysis in the mouse. Physiology and Behavior, 66, 723-729.
  • Clarke, K. A., & Still, J. (2001). Development and consistency of gait in the mouse. Physiology and Behavior, 73, 159-164.
  • Dingwell, J. B., & Cusumano, J. P. (2000). Nonlinear time series analysis of normal and pathological human walking. Chaos, 10, 848-863.
  • Dingwell, J. B., Cusumano, J. P., Cavanagh, P. R., & Sternad, D. (2001). Local dynamic stability versus kinematic variability of continuous overground and treadmill walking. Journal of Biomechanical Engineering, 123, 27-32.
  • Dingwell, J. B., Ulbrecht, J. S., Boch, J., Becker, M. B., O'Gorman, J. T., & Cavanagh, P. R. (1999). Neuropathic gait shows only trends towards increased variability of sagittal plane kinematics during treadmill locomotion. Gait and Posture, 10, 21-29.
  • Fischer, L. R., Culver, D. G., Davis, A. A., Tennant, P., Wang, M., Coleman, M., et al. (2005). The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiology of Disease, 19, 293-300.
  • Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., et al. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Experimental Neurology, 185, 232-240.
  • Francis, K., Bach, J. R. & DeLisa, J. A. (1999). Evaluation and rehabilitation of patients with adult motor neuron disease. Archives of Physical Medicine and Rehabilitation, 80, 951-963.
  • Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W., & Caroni, P. (2000). Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. Journal of Neuroscience, 20, 2534-2542.
  • Gould, T. W, Buss, R. R, Vinsant, S., Prevette, D., Sun, W., Knudson, C. M., et al. (2006). Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. Journal of Neuroscience, 26, 8774-8786.
  • Grossblatt, N. (1996) Guide for the care and use of laboratory animals. Washington, DC: National Academy Press.
  • Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994, June). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 264, 1772-1775.
  • Herbin, M., Hackert, R., Gasc, J. P., & Renous, S. (2007). Gait parameters of treadmill versus overground locomotion in mouse. Behavioural Brain Research, 181, 173-179.
  • Jackson, C. E., & Bryan, W. W. (1998). Amyotrophic lateral sclerosis. Seminars in Neurology, 18, 27-39.
  • Kale, A., Amende, I., Meyer, G. P., Crabbe, J. C., & Hampton, T. G. (2004). Ethanol's effects on gait dynamics in mice investigated by ventral plane videography. Alcoholism, Clinical and Experimental Research, 28, 1839-1848.
  • Kennel, P. F., Finiels, F., Revah, F., & Mallet, J. (1996). Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: An electromyographic study. Neuroreport, 7, 1427-1431.
  • Knutsson, E. (1972). An analysis of Parkinsonian gait. Brain, 95, 475-486.
  • Leblond, H., L'Esperance, M., Orsal, D., & Rossignol, S. (2003). Treadmill locomotion in the intact and spinal mouse. Journal of Neuroscience, 23, 1141-1149.
  • Manning-Bog, A. B., Caudle, W. M., Perez, X. A., Reaney, S. H., Paletzki, R., Isla, M. Z., et al. (2007). Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiology of Disease, 27, 141-150.
  • Marsden, C. D. (1984). The pathophysiology of movement disorders. Neurologic Clinics, 2, 435-459.
  • Meredith, G. E., & Kang, U. J. (2006). Behavioral models of Parkinson's disease in rodents: A new look at an old problem. Movement Disorders, 21, 1595-1606.
  • Mokry, J. (1995). Experimental models and behavioural tests used in the study of Parkinson's disease. Physiological Research, 44, 143-150.
  • Morris, M. E., Huxham, F. E., McGinley, J., & Iansek, R. (2001). Gait disorders and gait rehabilitation in Parkinson's disease. Advances in Neurology, 87, 347-361.
  • Olanow, C. W., & Tatton, W. G. (1999). Etiology and pathogenesis of Parkinson's disease. Annual Review of Neuroscience, 22, 123-144.
  • Phillips, J. G., Bradshaw, J. L., Iansek, R., & Chiu, E. (1993). Motor functions of the basal ganglia. Psychological Research, 55, 175-181.
  • Richardson, J. R., & Miller, G. W. (2004). Acute exposure to aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels. Toxicology Letters, 148, 29-40.
  • Schallert, T., Whishaw, I. Q., Ramirez, V. D., & Teitelbaum, P. (1978, March). Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats. Science, 199, 1461-1463.
  • Sedelis, M., Schwarting, R. K., & Huston, J. P. (2001). Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behavioural Brain Research, 125, 109-125.
  • Stanford, J. A., Vorontsova, E., Surgener, S. P., Gerhardt, G. A., & Fowler, S. C. (2002). Aged Fischer 344 rats exhibit altered locomotion in the absence of decreased locomotor activity: Exacerbation by nomifensine. Neuroscience Letters, 333, 195-198.
  • Tillerson, J. L., Caudle, W. M., Parent, J. M., Gong, C., Schallert, T., and Miller, G. W. (2006). Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behavioural Brain Research, 172, 97-105.
  • Tillerson, J. L., Caudle, W. M., Reveron, M. E., & Miller, G. W. (2002). Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Experimental Neurology, 178, 80-90.
  • Tillerson, J. L., Caudle, W. M., Reveron, M. E., & Miller, G. W. (2003). Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience, 119, 899-911.
  • Tillerson, J. L., Cohen, A. D., Caudle, W. M., Zigmond, M. J., Schallert, T., & Miller, G. W. (2002). Forced nonuse in unilateral parkinsonian rats exacerbates injury. Journal of Neuroscience, 22, 6790-6799.
  • Tillerson, J. L., & Miller, G. W. (2003). Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. J Neuroscience Methods, 123, 189-200.
  • Vieregge, P., Stolze, H., Klein, C., & Heberlein, I. (1997). Gait quantitation in Parkinson's disease: Locomotor disability and correlation to clinical rating scales. Journal of Neural Transmission, 104, 237-248.
  • Walling, A. D. (1999). Amyotrophic lateral sclerosis: Lou Gehrig's disease. American Family Physician, 59, 1489-1496.
  • Wooley, C. M., Sher, R. B., Kale, A., Frankel, W. N., Cox, G. A., & Seburn, K. L. (2005). Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle and Nerve, 32, 43-50.
  • Zijlstra, W., Rutgers, A. W., & Van Weerden, T. W. (1998). Voluntary and involuntary adaptation of gait in Parkinson's disease. Gait Posture, 7, 53-63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.